Follow-The-Filings

Security

Jade Biosciences Inc. · COM NEW

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 new max 0.0% (Marshall Wace - Marshall ...)

owners 8
max % 0.0%
tracked value $61M
qoq N 1 A 5 R 1

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 944,776 $13M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 402,489 $6M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 2,095,767 $32M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 264,315 $4M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 160,051 $2M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 137,222 $2M hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 135,039 $2M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 16,496 $255 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$75.52M -$69.63M -$127.41M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $124.23M $80.12M $348.82M
Total non-current assets * $3.19M $215,000 $965,000
Total assets $127.42M $80.33M $349.78M
Total current liabilities $17.64M $3.83M $16.54M
Total non-current liabilities * $325,000 $70,000 $724,000
Total equity $109.46M $76.43M $332.52M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$56.78M -$71.2M -$94.69M
Cash from investing $11.88M $56.03M -$247.01M
Cash from financing $46M $25.43M $360.77M
Net change in cash $1.09M $10.26M $19.05M

ownership over time

filing count by report period · click a bar for that quarter’s holders